Fuller H B CO

H.B. Fuller Company announced an amendment to its Second Amended and Restated Credit Agreement, extending the maturity date and adjusting interest rate margins.

H.B. Fuller Company has launched a recommended cash offer to acquire Advanced Medical Solutions Group plc to expand its medical adhesives portfolio and increase its total addressable market by $15 billion.

H.B. Fuller reported strong second-quarter 2026 results with a 19% increase in adjusted EPS and record operating cash flow, leading to an upward revision of full-year guidance.

H.B. Fuller Company shareholders successfully elected three directors and ratified the appointment of Ernst & Young LLP at the 2026 Annual Meeting.

H.B. Fuller Company reported stronger-than-expected first-quarter adjusted earnings and EBITDA, leading to an increase in its full-year 2026 financial guidance.

H.B. Fuller Company announced robust fourth quarter and fiscal year 2025 results, highlighted by double-digit adjusted EPS growth and expanded adjusted EBITDA margins, despite a challenging economic environment.

H.B. Fuller reports strong Q2 2026 revenue growth and announces a definitive agreement to acquire Advanced Medical Solutions Group plc.

H.B. Fuller Company reported a significant increase in net income and diluted EPS for Q1 2026, despite a slight decrease in net revenue, driven by improved gross profit margins and strategic acquisitions.

H.B. Fuller Company reported a 21.3% increase in net income and a 24.5% rise in diluted EPS for the third quarter of 2025, driven by improved gross profit margins and strategic acquisitions, despite a slight revenue decline.

H.B. Fuller Company announced a significant decrease in net income and diluted earnings per share for the second quarter and first six months of fiscal year 2025, primarily driven by negative currency effects, higher interest expense, and discrete tax charges, despite achieving positive organic revenue growth and improved gross profit margins.

H.B. Fuller's first quarter 2025 net income decreased significantly due to lower revenue and increased raw material and manufacturing expenses.

H.B. Fuller's Q3 2024 net income rose to $55.4 million, up from $37.6 million in Q3 2023, driven by acquisitions and increased sales volume.

H.B. Fuller Company reports increased net income and gross profit margin in fiscal 2025 despite a slight revenue decrease, driven by strategic acquisitions and cost management.

H.B. Fuller's FY24 results show a revenue increase driven by acquisitions, despite challenges from pricing and currency fluctuations.

H.B. Fuller has established a policy to recoup incentive-based compensation from executives and key managers in cases of financial restatements or intentional misconduct.

John J Corkrean, Executive VP and CFO of Fuller H B Co, received 228 shares of common stock on July 31, 2026.

Heather Campe, Sr. VP, International Growth of Fuller H B Co, received 40 shares of common stock on July 31, 2026.

John J Corkrean, Executive VP and CFO of Fuller H B Co, received 221 shares of common stock on July 17, 2026.

Heather Campe, Sr. VP, International Growth of Fuller H B Co, received 39 shares of common stock on July 17, 2026.

Srilata Zaheer, a Director of Fuller H B Co, received 2,895 shares of common stock on July 15, 2026.

Trangsrud Teresa J Rasmussen, a Director of Fuller H B Co, received 2,895 shares of common stock on July 15, 2026.

H.B. Fuller Company announces its 2026 Annual Meeting of Shareholders, while highlighting strong fiscal 2025 financial results including record adjusted EBITDA margin and a 56th consecutive dividend increase.

H.B. Fuller Company has filed a definitive proxy statement with the Securities and Exchange Commission.

H.B. Fuller is asking shareholders to approve an amendment to their incentive plan to increase the number of shares available for issuance by 2,000,000 at the upcoming annual meeting on April 15, 2025.

H.B. Fuller Company has filed a definitive proxy statement with the Securities and Exchange Commission.

H.B. Fuller's proxy statement outlines key proposals for the upcoming annual meeting, including director elections, ratification of the auditor, and an advisory vote on executive compensation.

Vanguard Capital Management has reported beneficial ownership of 5.22% of HB Fuller Co.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.91% in HB Fuller Co. common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in HB Fuller Co following an internal realignment.

BlackRock, Inc. has reported an increased beneficial ownership of 14.4% in H.B. Fuller Company, holding 7,776,207 common shares.